Drug Topics

JANUARY 14, 2025

Rates of chlamydia and syphilis declined in adults taking HIV PrEP.

468

468

STAT

JANUARY 14, 2025

For the second time in less than a year, the U.S. Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs.

Insurance 142

Insurance 142

The Checkup by Singlecare

JANUARY 14, 2025

If youre living with diabeteswhether prediabetes , Type 2 diabetes , or Type 1 diabetes then youre probably taking steps to manage your blood glucose levels. Along with regular exercise, sufficient sleep, and taking care of your mental health, following a healthy, balanced meal plan is one of the most effective components of diabetes management. As you focus on maintaining healthy blood sugar levels, being mindful of your carbohydrate intake is likely at the forefront of your mind.

Health and Personal Care Stores 111

Health and Personal Care Stores Grocery Stores Labelling 111

PharmaVoice

JANUARY 14, 2025

Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.

290

290

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 14, 2025

RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.

281

281

STAT

JANUARY 14, 2025

After years of prodding, the National Institutes of Health has adopted a new policy requiring companies seeking licenses to sell medical products invented with government research to submit plans for ensuring greater access to patients. Going forward, a company would not only have to submit an access plan when seeking to license the rights to sell a drug, vaccine or device, but would also have to update that plan as product development progresses.

Vaccines 118

Vaccines 118

STAT

JANUARY 14, 2025

Eli Lilly’s expectations for sales in the fourth quarter of last year missed forecasts, driven by lower-than-expected sales of its diabetes and obesity drugs Mounjaro and Zepbound. This is another notable stumble for the company after its third-quarter earnings report disappointed. In the fourth quarter, the pharma giant expects to have brought in $13.5 billion in revenue, less than the $13.9 billion that analysts polled by FactSet had forecast.

110

110

Drug Topics

JANUARY 14, 2025

Ahead of its first general meeting in 2025, lawmakers called on the FTC to vote yes on releasing a second interim staff report on PBMs.

247

247

Pharmafile

JANUARY 14, 2025

Pharmapack Europe: Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and existing biomedical research infrastructure 18 December 2024 Paris, France New research released ahead of Pharmapack Europe the continents largest partnering event for medical device and packaging innovation has ranked the Basel region […] The post Switzerlands Basel Region Crowned Europes Top Destination to Launch a Drug Device Company, According to Ph

Packaging 64

Packaging 64

PharmaVoice

JANUARY 14, 2025

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.

147

147

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JANUARY 14, 2025

The FTC released its second interim staff report Tuesday during Chair Lina Khan's final open commission meeting, but declined to indicate whether it would take further legal action.

138

138

Pharmacy Times

JANUARY 14, 2025

Brentuximab vedotin is approved for treatment of adult and pediatric with classical Hodgkin lymphoma in combination with chemotherapy.

Chemotherapy 130

Chemotherapy 130

Fierce Healthcare

JANUARY 14, 2025

The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers and dealers to San Francisco.

131

131

Pharmacy Times

JANUARY 14, 2025

The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.

121

121

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 14, 2025

Chronic care management will continue to be an important growth driver for Teladoc, executives said. The company is teaming up with Amazon to make it easier for individuals to find and enroll in its virtual cardiometabolic programs.

129

129

Pharmaceutical Technology

JANUARY 14, 2025

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

105

105

Fierce Healthcare

JANUARY 14, 2025

The U.S. Supreme Court has agreed to hear a lawsuit that will determine whether preventive services will remain fully covered by group health plans under the Affordable Care Act (ACA). | The Supreme Court will decide the fate of the preventive services provision, a core component of the Affordable Care Act, by July.

121

121

STAT

JANUARY 14, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! There are just two days left to submit nominations for our annual STAT Madness competition. It’s a bracket-style tournament honoring the best innovation in biomedical research, and a lot of fun.

104

104

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JANUARY 14, 2025

In an interview at the J.P. Morgan Healthcare Conference on Tuesday, Morgan Health CEO Dan Mendelson told Fierce Healthcare that the firm's current portfolio of investments have focused on several key buckets within healthcare.

115

115

PhRMA

JANUARY 14, 2025

A ground-breaking New York Times investigation reveals how a for-profit federal contractor helps hospitals abuse the 340B program to charge huge markups on medicines. 340B has become a tool for profit, benefiting large hospital systems and private corporations far more than the patients it was designed to serve.

Hospitals 100

Hospitals 100

Fierce Healthcare

JANUARY 14, 2025

The Department of Health and Human Services released an AI Strategic Plan Jan. 10 that lays out short-term and long-term goals for ensuring AI is safe and trustworthy when deployed in healthcare. The plan emphasizes technical assistance for under-resourced organizations and workforce training initiatives.

112

112

PharmaVoice

JANUARY 14, 2025

A series of uncertainties that kept dealmaking to a minimum last year could be reversing as pharma reloads pipelines ahead of the patent cliff explosion.

100

100

Fierce Healthcare

JANUARY 14, 2025

Cigna has tapped Progyny as it looks to enhance access to benefits for fertility and family planning services. | Cigna has tapped Progyny as it looks to enhance access to benefits for fertility and family planning services.

108

108

Pharmaceutical Technology

JANUARY 14, 2025

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.

97

97

pharmaphorum

JANUARY 14, 2025

FDA has started its review of an autoinjector version of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to be dosed at home

FDA 96

FDA 96

Outsourcing Pharma

JANUARY 14, 2025

Johnson & Johnson's $14.

84

84

pharmaphorum

JANUARY 14, 2025

NICE has said that four artificial intelligence technologies can be deployed by the NHS to detect fractures on X-rays in urgent care.

94

94

PioneerRx

JANUARY 14, 2025

At the time of writing, out-of-control wildfires are ripping across parts of Los Angeles, leading to at least 24 deaths, burning down hundreds of buildings.

81

81

Outsourcing Pharma

JANUARY 14, 2025

Spotlighting innovation at the SCOPE Summit, finalists for the Site Innovation and Patient Engagement Awards showcase groundbreaking tools, AI solutions, and diversity-driven initiatives set to transform clinical trials.

78

78

pharmaphorum

JANUARY 14, 2025

Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start

75

75

Fierce Healthcare

JANUARY 14, 2025

At 2024s J.P. | Work to unify disparate programs has the $37 billion nonprofit system on an upward trajectory, CEO Wright Lassiter III told conference attendees.

74

74

Pharmacy Times

JANUARY 14, 2025

Wildfire smoke carries toxic compounds that can trigger respiratory inflammation and cause cellular damage.

Compounding 73

Compounding 73

Fierce Healthcare

JANUARY 14, 2025

Global investment firm KKR led the mega round. Qventus said it's finding a new level of resonance with investors and customers for its hospital efficiency products since it launched over 10 years ago.

Hospitals 71

Hospitals 71